FDA Approved: PANCREAZE — Supplemental Application (VIVUS LLC)

View source ↗

Summary

FDA approved a supplemental application for Pancreaze (pancrelipase) by VIVUS LLC, expanding labeling/indications related to exocrine pancreatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatic Cancer
• Pancreatitis

Drugs mentioned

• Pancreaze (pancrelipase)

Snippet

SUPPL AP for PANCREAZE (PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE)